GlassScriptPhysician profile
John P Dorval
NPI 1164081667
$1,616.16
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $504 · 2023: $451 · 2024: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $679.06 | 2021-2024 | |
| Alkermes, INC. | $156.29 | 2021-2022 | |
| Glaxosmithkline, LLC. | $93.81 | 2022-2024 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $93.06 | 2021-2024 | Mounjaro, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $92.03 | 2023-2024 | Caplyta |
| Exact Sciences Corporation | $87.56 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $56.90 | 2023-2024 | Breztri |
| Pfizer INC. | $51.87 | 2022-2024 | |
| Seqirus USA INC | $43.30 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Novo Nordisk INC | $42.56 | 2021 | |
| Phathom Pharmaceuticals, INC. | $29.02 | 2024 | Voquezna |
| Vanda Pharmaceuticals INC. | $27.58 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.43 | 2022 | |
| Braeburn INC. | $26.20 | 2024 | Brixadi |
| Axsome Therapeutics, INC. | $24.92 | 2023 | Sunosi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $24.00 | 2024 | Sublocade |
| Jazz Pharmaceuticals INC. | $22.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.44 | 2021 | |
| Corium, LLC | $18.13 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dorval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.